Cellworks

Precise, Transparent, Cost-effective Personalized Cancer Care

San Jose, United States · Founded 2005 · $5.0M raised

Employees
51–200
Founded
2005
Business Model
B2B
Total Funding
$5.0M
Last Round
$5.0M Series AJan 2009
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Founded in 2005 and backed by UnitedHealth Group, Sequoia Capital, Agilent and Artiman, Cellworks has built a trans-disciplinary team of molecular biologists, cellular pathway modelers, and software technologists. The Cellworks Platform uses multi-omics modeling, computational biosimulation, and AI to predict the most efficacious therapies for individual patients — generating a Therapy Response Index (TRI) report for physicians. The platform goes beyond the one-mutation, one-drug NGS paradigm to evaluate multiple aberrations and alternative therapy options. Cellworks also assists BioPharma in improving clinical trial success rates and resurrecting failed drugs, with therapeutic focus in oncology and immunology.

Summary

Cellworks is a Biotech company based in San Jose, United States, founded in 2005. It has raised $5.0M in total across 1 round, most recently a $5.0M Series A round in Jan 2009. Investors include Artiman Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries A2009 (est.)
$5.0M

Investors

Similar Companies

GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellworks on Indexed.vc
<a href="https://indexed.vc/companies/cellworks"><img src="https://indexed.vc/api/badge/company/cellworks" alt="Cellworks on Indexed.vc" width="260" height="76" /></a>